Benzathine Analog Applications in Environmental Monitoring, Agriculture, Food Safety, Wildfire Prevention, and Skin Health

Publication ID: 24-11857550_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Benzathine Analog Applications in Environmental Monitoring, Agriculture, Food Safety, Wildfire Prevention, and Skin Health,” Published Technical Disclosure No. 24-11857550_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857550_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,550.

Summary of the Inventive Concept

The inventive concept expands the core technology of benzathine analogs to new industries, addressing environmental pollution, crop yields, food safety, wildfire prevention, and skin disorders by leveraging the compounds' ability to inhibit pro-inflammatory cytokine release.

Background and Problem Solved

The original patent focused on treating inflammatory disorders in humans. However, the limitations of this approach led to unexplored opportunities in other fields. The inventive concept tackles these limitations by applying the core technology to entirely new areas, addressing pressing issues such as environmental pollution, crop yields, food safety, wildfire prevention, and skin disorders.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of applications, including environmental monitoring systems that detect pro-inflammatory cytokine levels in wastewater to adjust chemical treatment processes, methods for improving crop yields by reducing plant stress through benzathine analog application, devices for detecting and quantifying pro-inflammatory cytokines in food products, systems for predicting and preventing wildfires based on soil cytokine levels, and methods for treating and preventing skin disorders by inhibiting pro-inflammatory cytokine release in skin cells.

Novelty and Inventive Step

The new claims introduce novel applications of benzathine analogs, which are non-obvious extensions of the original patent's technology. The inventive concept's novelty lies in its ability to adapt the compounds' pro-inflammatory cytokine inhibition properties to diverse industries and problems.

Alternative Embodiments and Variations

Alternative embodiments may include variations in sensor design for environmental monitoring, different formulations of benzathine analogs for agricultural use, and modifications to the biosensor design for food safety applications. These variations can ensure broad conceptual coverage and adaptability to different industries and use cases.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in multiple industries, including environmental monitoring, agriculture, food safety, wildfire prevention, and skin health. The target markets include industrial settings, agricultural companies, food manufacturers, government agencies, and skincare product developers, offering a wide range of opportunities for partnerships, licensing, and product development.

Field of Art

Pharmaceutical biotechnology with expertise in immunomodulatory compounds, cytokine research, and cross-industry applications of molecular inhibition technologies

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in biochemistry, pharmacology, or bioengineering, possessing knowledge of cytokine signaling, molecular inhibition techniques, and interdisciplinary technology transfer

Obviousness Rationale

The PTD demonstrates predictable extensions of the source patent's core technology by applying the benzathine analog's pro-inflammatory cytokine inhibition mechanism to novel domains. A PHOSITA would recognize that the compound's fundamental molecular action could be readily adapted to environmental, agricultural, and diagnostic applications by leveraging its established cytokine modulation properties. The variations represent logical, incremental innovations that apply a known molecular mechanism to solve problems in adjacent technical domains.

Obvious Combinations & Variations

Source Patent Element
Method of inhibiting pro-inflammatory cytokine release in medical contexts
PTD Variation
Environmental monitoring systems detecting cytokine levels in wastewater
Obviousness Reasoning
Predictable application of cytokine detection technology to industrial process monitoring, representing a known technique of adapting biological sensing mechanisms to environmental analysis
Source Patent Element
Treating inflammatory disorders through cytokine inhibition
PTD Variation
Reducing plant stress by inhibiting pro-inflammatory cytokine release in agricultural contexts
Obviousness Reasoning
Obvious extension of molecular mechanism to plant biology, utilizing known principles of cellular stress response and molecular signaling across biological systems
Source Patent Element
Targeting specific inflammatory responses in human medical conditions
PTD Variation
Biosensor technologies for detecting pro-inflammatory cytokines in food safety applications
Obviousness Reasoning
Straightforward adaptation of existing molecular detection techniques to a related diagnostic domain, representing a predictable technological transfer
Source Patent Element
Inhibiting cytokine release in response to pathogenic triggers
PTD Variation
Wildfire prediction systems based on soil cytokine level monitoring
Obviousness Reasoning
Logical application of inflammatory response detection to environmental risk assessment, utilizing known principles of molecular signaling in stress response mechanisms
35 U.S.C. § 103 Summary: Based on US Patent 11857550's disclosure of benzathine analog mechanisms for inhibiting pro-inflammatory cytokine release, the present publication demonstrates that the claimed variations represent obvious extensions of the original technological concept. A person having ordinary skill in the art would readily recognize the predictable application of the molecular inhibition mechanism across diverse technical domains, rendering subsequent claims involving similar technological adaptations obvious and non-patentable.

Original Patent Information

Patent NumberUS 11,857,550
TitleBenzathine analogs
Assignee(s)UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, United States Government As Represented By The Department Of Veterans Affairs